Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

被引:4
|
作者
Patlolla, Sri Harsha [1 ]
Schaff, Hartzell V. [1 ]
Nishimura, Rick A. [2 ]
Eleid, Mackram F. [2 ]
Geske, Jeffrey B. [2 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, 200 First Street SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
来源
关键词
disparities; ethnicity; hypertrophic cardiomyopathy; race; septal reduction; MYECTOMY; ABLATION; VOLUME;
D O I
10.1161/JAHA.122.026661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundInformation on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited. Methods and ResultsUsing the National Inpatient Sample from January 2012 through December 2019, we identified all adult admissions with a primary diagnosis of obstructive hypertrophic cardiomyopathy and those undergoing SRT. Predictors of receiving SRT and outcomes including in-hospital mortality, complications, and resource use were evaluated in racial and ethnic groups. Among a total of 18 895 adult admissions with obstructive hypertrophic cardiomyopathy, SRT was performed in 7255 (38.4%) admissions. Septal myectomy was performed in 4930 (26.1%), while alcohol septal ablation was performed in 2325 (12.3%). In adjusted analysis, Black patient (versus White patient adjusted odds ratio, 0.65 [95% CI, 0.57-0.73]; P<0.001) and Hispanic patient admissions (versus White adjusted odds ratio, 0.78 [95% CI, 0.66-0.92]; P=0.003) were less likely to receive SRT. Among admissions undergoing SRT, in-hospital mortality was significantly higher for Hispanic (adjusted odds ratio, 3.38 [95% CI, 1.81-6.30], P<0.001) and other racial and ethnic groups (adjusted odds ratio 2.02 [95% CI, 1.00-4.11]; P=0.05) compared with White patient admissions, whereas Black patient admissions had comparable mortality. Black, Hispanic, and other ethnic group patients had higher rates of SRT complications and more frequent dismissals to acute care facilities. ConclusionsAmong obstructive hypertrophic cardiomyopathy hospitalizations, minoritized racial groups were less likely to receive SRT. Importantly, hospitalizations of Hispanic and other ethnic patients undergoing SRT had significantly higher in-hospital mortality and complication rates. Further studies with granular echocardiographic information to assess indications for SRT are needed to better understand these differences.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] SEPTAL COILING FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Balan, Prakash
    Denktas, Ali
    Smalling, Richard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1566 - E1566
  • [32] COVID-19 Impacted Septal Reduction Therapies in Hypertrophic Cardiomyopathy
    Desai, Spandan
    Roma, Nicholas
    Pattoli, Megan
    Durkin, Matthew
    Shah, Kashyap
    Amaratunga, Eluwana
    Magid, Lindsey
    Yellapu, Vikas
    Shirani, Jamshid
    CIRCULATION, 2024, 150
  • [33] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [34] A novel hybrid approach to nonsurgical septal reduction in hypertrophic obstructive cardiomyopathy
    Bezgin, Tahir
    Celik, Aziz Inan
    Baytugan, Nart Zafer
    Cagdas, Metin
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2024, 82 (10): : 1013 - 1014
  • [35] Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
    Lakkis, NM
    Nagueh, SF
    Kleiman, NS
    Killip, D
    He, ZX
    Verani, MS
    Roberts, R
    Spencer, WH
    CIRCULATION, 1998, 98 (17) : 1750 - 1755
  • [37] Outcomes of Septal Myectomy and Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: The Stanford Experience
    Tibayan, Yen
    Sedehi, Daniel
    Chi, Jeffrey
    Pavlovic, Alexsandra
    Salisbury, Heidi
    Wheeler, Matthew
    Ho, Michael Y.
    Sgroi, Michael
    Kim, Young
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Lee, David P.
    Ashley, Euan A.
    CIRCULATION, 2009, 120 (18) : S864 - S864
  • [38] Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy
    Geske, Jeffrey B.
    Driver, C. Noelle
    Yogeswaran, Vidhushei
    Ommen, Steve R.
    Schaff, Hartzell, V
    AMERICAN HEART JOURNAL, 2020, 221 : 159 - 164
  • [39] Early post-septal myectomy outcomes for hypertrophic obstructive cardiomyopathy
    Afanasyev, Alexandr, V
    Bogachev-Prokophiev, Alexandr, V
    Zheleznev, Sergei, I
    Zalesov, Anton S.
    Budagaev, Sergei A.
    Shajahmetova, Svetlana, V
    Nazarov, Vladimir M.
    Demin, Igor I.
    Sharifulin, Ravil M.
    Pivkin, Alexey N.
    Astapov, Dmitriy A.
    Cherniavsky, Alexandr M.
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2022, 30 (01): : 74 - 83
  • [40] Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy
    Liebregts, Max
    Faber, Lothar
    Jensen, Morten K.
    Vriesendorp, Pieter A.
    Januska, Jaroslav
    Krejci, Jan
    Hansen, Peter R.
    Seggewiss, Hubert
    Horstkotte, Dieter
    Adlova, Radka
    Bundgaard, Henning
    ten Berg, Jurrien M.
    Veselka, Josef
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (11) : 1135 - 1143